Return to content in this issue

Rituximab as a Single Agent for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immune Deficiency

Tessarin G¹, Bondioni MP², Rossi S¹, Palumbo L³, Soresina A³, Badolato R¹, Plebani A¹, Lougaris V<sup>1

1</sup>Pediatrics Clinic, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy
²Pediatric Radiology, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy
³Pediatrics Clinic, ASST-Spedali Civili of Brescia, Brescia, Italy

J Investig Allergol Clin Immunol 2019; Vol 29(6) : 470-471
doi: 10.18176/jiaci.0450

• Abstract
• Supplemental Materials

Key words: Rituximab, Common variable immunodeficiency, Granulomatous lymphocytic interstitial lung disease, B cell, Tertiary lymphoid structures

	Title	Type	Size
	doi10.1876_jiaci.0450_material-suppl.pdf	pdf	233.00 Kb